Advertisement

Topics

Search Results for "Pharmac Cost Of Sativex In New Zealand"

14:30 EDT 24th July 2017 | BioPortfolio

Matching Channels

Marginal cost

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

CombiCult

CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Matching News

Bendamustine funding approved in New Zealand

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

Decision to award sole supply of metoprolol succinate in New Zealand

New Zealand’s Pharmaceutical Management Agency PHARMAC today announced the approval of an agreement…

Several new brands showcased in Pharmac South expo, 10% hike expected in business

The 3rd edition of the south Indian pharma industry's product profile expo, 'Pharmac South 2017', concluded on last Saturday, has served as an ideal platform for the pharma manufacturers and marketers...

Chennai to host fourth edition of Pharmac South on July 7─8; 3,000 visitors expected to participate

The fourth edition of the Pharmac South, south India's pharmaceutical products and machinery expo, convention and awards event, will be held in Chennai on July 7 and 8 at Chennai Trade Centre.

Dr J Radhakrishnan to inaugurate Pharmac South 2017 in Chennai on July 7.

Pharmac South 2017, the third edition of the south Indian trade show will be held from July 7 to 8 at Chennai Trade Centre.The event will be inaugurated by Dr J Radhakrishnan, Principal Secretary, dep...

Hunan Zhaotai Forms New Zealand JV for Cancer Drug Development

Hunan Zhaotai Medical Group has formed a cancer treatment JV with New Zealand's Malaghan Institute, which will conduct clinical trials on Zhaotai's CAR-T cancer drug portfolio in New Zealand. Zhaotai ...

China's Premier Li arrives in New Zealand for talks

WELLINGTON, New Zealand (AP) — China's premier has arrived in New Zealand for high-level talks at a time that both countries are pushing to expand free trade.

Royal Society of New Zealand kicks off 150th celebrations

It’s a big day for the Royal Society of New Zealand Te Apārangi as it welcomes guests from all over the world to begin six months of celebrations around its 150th anniversary. I’ve been a...

Matching PubMed Articles

Patient response to use of tyrosine kinase inhibitors in lung cancer: a retrospective audit during funding changes.

The New Zealand Pharmaceutical Management Agency (PHARMAC) approved funding of erlotinib in October 2010 as second line therapy in all non-squamous non-small cell lung cancer after platinum-based chem...

A wealth of tobacco control research in New Zealand: time for the New Zealand Government to do its bit.

High incidence of medulloblastoma in Māori and Pacific populations in New Zealand.

In New Zealand from 1995-2010, the incidence of medulloblastoma at ages 1-19 years was significantly higher in Māori (relative risk 2.0) and in Pacific peoples (RR 2.1) than in New Zealand Europeans.

Traditional Chinese medicine practitioners in New Zealand: differences associated with being a practitioner in New Zealand compared to China.

While New Zealand has experienced an increase in the use of traditional Chinese medicine (TCM) based acupuncture, very little is known about the practitioners who provide this type of treatment modali...

Psychosocial enhancement of the Green Prescription for obesity recovery: a randomised controlled trial.

Kia Ākina is a low-cost obesity recovery network providing ongoing addiction-orientated psychosocial support. This study explored the impact of Kia Ākina when added to the Green Prescription, a key ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement